EP05.02-008. Phase II Trial of Neoadjuvant Icotinib Plus Chemotherapy for Stage II-IIIB EGFR-mutant Non-small-Cell Lung Cancer
Back to course
Pdf Summary
Asset Subtitle
Fang-Liang Lu
Meta Tag
Speaker Fang-Liang Lu
Topic Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
Keywords
neoadjuvant therapy
icotinib
EGFR tyrosine kinase inhibitor
chemotherapy
stage II-IIIB EGFR-mutant NSCLC
major pathological response
pathological complete response
overall survival
disease-free survival
tumor response
Powered By